Abivax: 2020 Financial Communication Calendar
Publication of 2019 Financial Statements
Publication and Release of the 2019 Annual Financial Report
Shareholders meeting
Publication of Financial Statements as of
Publication and Release of 2020 Half Year Report
About
DISCLAIMER
This press release contains forward-looking statements, forecasts and estimates with respect to certain of the Company's programs. Although the Company believes that its forward-looking statements, forecasts and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors that have been deemed reasonable, such forward-looking statements, forecasts and estimates are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated in such forward-looking statements, forecasts and estimates. A description of these risks, contingencies and uncertainties can be found in the documents filed by the Company with the French Autorité des Marchés Financiers pursuant to its legal obligations including its registration document (Document de Référence). Furthermore, these forward-looking statements, forecasts and estimates are only as of the date of this press release. Readers are cautioned not to place undue reliance on these forward-looking statements.
This press release is for information purposes only, and the information contained herein does not constitute either an offer to sell, or the solicitation of an offer to purchase or subscribe securities of the Company in any jurisdiction, in particular in
View source version on businesswire.com: https://www.businesswire.com/news/home/20200119005014/en/
Source:
ABIVAX
CFO
Didier Blondel
didier.blondel@abivax.com
+33 1 53 83 08 41
Financial communications France
Actifin
Ghislaine Gasparetto
ggasparetto@actifin.fr
+33 1 56 88 11 22
Investor relations
LifeSci Advisors
Chris Maggos
chris@lifesciadvisors.com
+41 79 367 6254